Metraipolis › archive › dc_7ee724bb6e72
SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art — Europe PMC PMID:41487902
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41487902
- DOI
- 10.1093/ckj/sfaf350
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T13:36:59.158Z
- SHA-256 of the archived text
185eeed846d9b8a2bc0703d374029fe66355b8df124c94e30b673b0f42f76f31- Stable URL of this page
https://metraipolis.com/documento/dc_7ee724bb6e72
How to cite
SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art — Europe PMC PMID:41487902 — Europe PMC (en), https://europepmc.org/article/MED/41487902 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ee724bb6e72 (Metraipolis archive dc_7ee724bb6e72, sha256 185eeed846d9b8a2bc0703d374029fe66355b8df124c94e30b673b0f42f76f31)
BibTeX
@misc{dc7ee724bb6e72,
title = {SGLT2 inhibitors in hemodialysis or peritoneal dialysis patients: rationale and state-of-the art — Europe PMC PMID:41487902},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41487902},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ee724bb6e72; sha256 185eeed846d9b8a2bc0703d374029fe66355b8df124c94e30b673b0f42f76f31},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41487902. Agents can read the archived copy with the MCP tool read_document.